Ryan Cohlhepp
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ryan Cohlhepp
Ryan Cohlhepp was last confirmed as Board Member at Bicara Therapeutics Inc. (BCAX) in a filing dated April 25, 2025. The proxy statement of Bicara Therapeutics Inc. reports total compensation of $858,400 for Ryan Cohlhepp in fiscal 2025, including a base salary of $588,000. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2024-01-01–2025-04-25
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Bicara Therapeutics Inc. (BCAX) | Pharm.D. President and Chief Operating Officer | $588,000 | $858,400 |
| 2024 | Bicara Therapeutics Inc. (BCAX) | Pharm.D. President and Chief Operating Officer | $517,500 | $4,467,589 |
| 2023 | Bicara Therapeutics Inc. (BCAX) | Pharm.D. President and Chief Operating Officer | $450,000 | $3,158,786 |
Recent activity
No call appearances or filed executive changes recorded yet.